Frontiers in Oncology | Hematologic Malignancies

Case Report

Published on 18 Nov 2025

A case report focusing on diagnosis and intervention of chronic myeloid leukemia in blast crisis (acute megakaryoblastic leukemia subtype)

in Hematologic Malignancies

Long Liu
Yang Xiao
Na Cui
Liping Zhang
Lijing Wang
Cheng Gao
Jingfei Shi
Changyong Yuan
Chao Cui

Frontiers in Oncology

doi 10.3389/fonc.2025.1711432

1,029 views

Brief Research Report

Published on 18 Nov 2025

GIMEMA survey on the management of chronic myeloid leukemia patients in the third line and beyond: insights from Italian hematologists

in Hematologic Malignancies

Massimo Breccia
Alfonso Piciocchi
Elisabetta Abruzzese
Daniela Cilloni
Fausto Castagnetti
Monica Messina
Stefano Soddu
Barbara Scappini
Uros Markovic
Mario Annunziata

Frontiers in Oncology

doi 10.3389/fonc.2025.1697569

1,403 views

Original Research

Published on 17 Nov 2025

Longitudinal analysis of usage and public awareness of tyrosine kinase inhibitors for CML

in Hematologic Malignancies

Adrian E. Schroer
Tiffany Javadi
Ankit Mehta
Furkan Torlak
Joseph R. McFarland
Girish Kumar
Alexandre L. da Silva
Jamaal Benjamin
Moaz M. Choudhary
Akram Sadeghi

Frontiers in Oncology

doi 10.3389/fonc.2025.1711453

1,951 views

Editorial

Published on 13 Nov 2025

Editorial: Antibody-based novel target immunotherapy in hematological malignancy

in Hematologic Malignancies

Weijie Cao
Yingmei Li
Haizhou Xing
Zhongxing Jiang
Jifeng Yu

Frontiers in Oncology

doi 10.3389/fonc.2025.1727734

1,054 views

Correction

Published on 13 Nov 2025

Correction: Case Report: Unraveling complex genomic alterations in a case of chronic lymphocytic leukemia using optical genome mapping

in Hematologic Malignancies

Leila Youssefian
Sahoo Trilochan
Jia-Chi Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1707033

722 views

Brief Research Report

Published on 12 Nov 2025

Retrospective analysis of sorafenib combined with interferon α-1b, interleukin-2, and thalidomide as maintenance therapy in FLT3-ITD-positive acute myeloid leukemia

in Hematologic Malignancies

Cheng Cheng
Ruihua Mi
Dongbei Li
Lin Chen
Xudong Wei

Frontiers in Oncology

doi 10.3389/fonc.2025.1698935

1,278 views

Case Report

Published on 12 Nov 2025

Case Report: Iatrogenic dyspnea and respiratory failure in a multiple myeloma patient treated with carfilzomib

in Hematologic Malignancies

Giuseppe Bertuglia
Mattia Verardo
Matilde Scaldaferri
Mauro Mangiapia
Benedetto Bruno
Alessandra Larocca

Frontiers in Oncology

doi 10.3389/fonc.2025.1701639

1,439 views
2 citations

Case Report

Published on 11 Nov 2025

Case Report: Rare adverse events following CAR-T therapy in patients with relapsed/refractory diffuse large B-cell lymphoma

in Hematologic Malignancies

Ziniya Shah
Ranju Kunwor

Frontiers in Oncology

doi 10.3389/fonc.2025.1644818

2,241 views
1 citation

Case Report

Published on 07 Nov 2025

Resistance to imatinib in a ETV6::PDGFRB rearranged myeloid/lymphoid neoplasm with high-risk mutations: a case report

in Hematologic Malignancies

Lucia Cavelier
Leonie Saft
Birgitta Sander
Stefan Deneberg

Frontiers in Oncology

doi 10.3389/fonc.2025.1611747

1,633 views

Brief Research Report

Published on 07 Nov 2025

Integrated CIRCLE-seq with RNA-seq to decipher the quantity, localization, and functional features of eccDNA in AML

in Hematologic Malignancies

Lijuan Gao
Qiongyu Lu
Hao Li
Changgen Ruan
Zhao Zeng
Suning Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1701989

1,574 views

Original Research

Published on 05 Nov 2025

Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron era

in Hematologic Malignancies

Akinao Okamoto
Masahiro Yoshida
Senji Kasahara
Takahide Ara
Kazutaka Ozeki
Takanobu Morishita
Daisuke Ikeda
Minoru Kanaya
Tomohiro Kajiguchi
Yasuhiro Suzuki

Frontiers in Oncology

doi 10.3389/fonc.2025.1687204

1,968 views

Systematic Review

Published on 04 Nov 2025

Efficacy and safety of inotuzumab ozogamicin and its combination therapies in acute lymphoblastic leukemia: a systematic review and meta-analysis

in Hematologic Malignancies

Changtao Lao
Jiange Wen
Yuezhen Wen

Frontiers in Oncology

doi 10.3389/fonc.2025.1613777

2,084 views

Original Research

Published on 04 Nov 2025

Mesenchymal stem cells added to second-line therapy improve response and failure-free survival in steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A meta-analysis of randomized controlled trials

in Hematologic Malignancies

Man Xiao
Yinghu Yan
Rui Zhang
Dan Wang
Li Wang
Yameng Zhao
Jinhong Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1704963

2,059 views

Original Research

Published on 03 Nov 2025

Relapsed or refractory central nervous system lymphoma successfully treated by glofitamab combined with lenalidomide

in Hematologic Malignancies

Yin-yin Peng
Xiao-qiong Tang

Frontiers in Oncology

doi 10.3389/fonc.2025.1685271

1,960 views

Original Research

Published on 31 Oct 2025

Prognostic value of lymphocyte subsets in diffuse large B cell lymphoma

in Hematologic Malignancies

Lihua Qiu
Lijing Xing
Meng Zhao
Biwen Sun
Xinpei Zhou
Min Li
Guoguang Ying
Huilai Zhang
Chen Tian

Frontiers in Oncology

doi 10.3389/fonc.2025.1671062

1,629 views

Perspective

Published on 31 Oct 2025

Unmet needs in patients with acute myeloid leukemia ineligible for intensive approaches: perspectives from a European expert panel

in Hematologic Malignancies

Felicetto Ferrara
Klaus Geissler
Priyanka Mehta
Pau Montesinos
Adriano Venditti

Frontiers in Oncology

doi 10.3389/fonc.2025.1642472

2,850 views

Systematic Review

Published on 31 Oct 2025

Safety of totally implantable venous access devices and peripherally inserted central catheters in hematological malignancies patients: a meta-analysis

in Hematologic Malignancies

Meier Gu
Xiaguang Huang

Frontiers in Oncology

doi 10.3389/fonc.2025.1679363

1,248 views

Original Research

Published on 30 Oct 2025

Testicular lymphoma of 63 patients: a Chinese retrospective, real-world study

in Hematologic Malignancies

Honghan Qiao
Sijun Zhang
Yukai Duan
Renjie Hua
Feiyang Zong
Mingzhi Zhang
Xudong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1652944

1,457 views

Editorial

Published on 30 Oct 2025

Editorial: Metabolic dysregulation in hematological malignancies: emerging insights and therapeutic implications

in Hematologic Malignancies

Pengcheng Liu
Jiao Ma
Zizhen Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1701952

971 views

Systematic Review

Published on 30 Oct 2025

Addition of daratumumab to standard triplet regimens achieved better survival in newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials

in Hematologic Malignancies

Bin Hu
Jun Wang
Dan Fang
Ling Jiang
Tianqi Li
Jinxia Cao

Frontiers in Oncology

doi 10.3389/fonc.2025.1619115

1,979 views

Original Research

Published on 28 Oct 2025

Efficacy and safety of hetrombopag in the treatment of chemotherapy-related thrombocytopenia in solid tumors: a retrospective study

in Hematologic Malignancies

Yuan Yuan
Qiang Tong
Jia-hui Liu
Ye Kang

Frontiers in Oncology

doi 10.3389/fonc.2025.1670029

1,541 views

Original Research

Published on 28 Oct 2025

The prognostic significance of incomplete hematological recovery in pediatric patients with low/intermediate risk AML and negative MRD after induction 1

in Hematologic Malignancies

Nessma M. Shahin
Mahmoud Hammad
Hanafy Hafez
Sherine Salem
Nahla El-Sharkawy
Amr Elnashar
Leslie Lehmann
Alaa El-Haddad

Frontiers in Oncology

doi 10.3389/fonc.2025.1661036

1,670 views

Case Report

Published on 27 Oct 2025

Case Report: Venetoclax combined with hypomethylating agents for the treatment of newly diagnosed with mixed-phenotype acute leukemia and a literature review

in Hematologic Malignancies

Ruihua Mi
Shuli Guo
Weidong Yang
Lin Wang
Yixuan Ma
Lin Chen
Dongbei Li
Xudong Wei

Frontiers in Oncology

doi 10.3389/fonc.2025.1693061

1,152 views

Editorial

Published on 27 Oct 2025

Editorial: Immunotherapy and cell therapy for patients with relapsed and refractory acute myeloid leukemia

in Hematologic Malignancies

JingYi Huang
ShiYao Song
Xiaotian Zhang
Chunliang Li
Yan-Lai Tang

Frontiers in Oncology

doi 10.3389/fonc.2025.1691911

1,147 views

2,059 articles

articles

A case report focusing on diagnosis and intervention of chronic myeloid leukemia in blast crisis (acute megakaryoblastic leukemia subtype)

GIMEMA survey on the management of chronic myeloid leukemia patients in the third line and beyond: insights from Italian hematologists

Longitudinal analysis of usage and public awareness of tyrosine kinase inhibitors for CML

Editorial: Antibody-based novel target immunotherapy in hematological malignancy

Correction: Case Report: Unraveling complex genomic alterations in a case of chronic lymphocytic leukemia using optical genome mapping

Retrospective analysis of sorafenib combined with interferon α-1b, interleukin-2, and thalidomide as maintenance therapy in FLT3-ITD-positive acute myeloid leukemia

Case Report: Iatrogenic dyspnea and respiratory failure in a multiple myeloma patient treated with carfilzomib

Case Report: Rare adverse events following CAR-T therapy in patients with relapsed/refractory diffuse large B-cell lymphoma

Resistance to imatinib in a ETV6::PDGFRB rearranged myeloid/lymphoid neoplasm with high-risk mutations: a case report

Integrated CIRCLE-seq with RNA-seq to decipher the quantity, localization, and functional features of eccDNA in AML

Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron era

Efficacy and safety of inotuzumab ozogamicin and its combination therapies in acute lymphoblastic leukemia: a systematic review and meta-analysis

Mesenchymal stem cells added to second-line therapy improve response and failure-free survival in steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A meta-analysis of randomized controlled trials

Relapsed or refractory central nervous system lymphoma successfully treated by glofitamab combined with lenalidomide

Prognostic value of lymphocyte subsets in diffuse large B cell lymphoma

Unmet needs in patients with acute myeloid leukemia ineligible for intensive approaches: perspectives from a European expert panel

Safety of totally implantable venous access devices and peripherally inserted central catheters in hematological malignancies patients: a meta-analysis

Testicular lymphoma of 63 patients: a Chinese retrospective, real-world study

Editorial: Metabolic dysregulation in hematological malignancies: emerging insights and therapeutic implications

Addition of daratumumab to standard triplet regimens achieved better survival in newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials

Efficacy and safety of hetrombopag in the treatment of chemotherapy-related thrombocytopenia in solid tumors: a retrospective study

The prognostic significance of incomplete hematological recovery in pediatric patients with low/intermediate risk AML and negative MRD after induction 1

Case Report: Venetoclax combined with hypomethylating agents for the treatment of newly diagnosed with mixed-phenotype acute leukemia and a literature review

Editorial: Immunotherapy and cell therapy for patients with relapsed and refractory acute myeloid leukemia